Brigitte Frohnert

Associate Professor

Barbara Davis Center for Childhood Diabetes

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Brigitte Frohnert is an Associate Professor at the Barbara Davis Center for Childhood Diabetes in the United States. Her research focuses on type 1 diabetes, including early diagnosis, risk assessment, and the integration of metabolic and genetic data to predict disease progression. Recent publications highlight her work on glucose monitor metrics, anxiety in parents of at-risk children, and the impact of technology on pediatric health outcomes.

Articles (12)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (7)

Riitta Veijola

Professor and Chief Physician in Paediatrics

Oulu University Hospital

FINLAND

View details

Greg Forlenza

Assistant Professor

Barbara Davis Center for Childhood Diabetes

UNITED STATES

View details

Stephen Rich

Harrison Professor and Founding Director (Emeritus)

University of Virginia

UNITED STATES

View details

Bart Keymeulen

Vrije Universiteit Brussel

BELGIUM

View details

Josefine Jönsson

Lund University

SWEDEN

View details

Marian J Rewers

University of Colorado Anschutz Medical Campus

UNITED STATES

View details

Bin Liu

West Virginia University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brigitte Frohnert

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development

Anxiety and Risk Perception in Parents of Children Identified by Population Screening as High Risk for Type 1 Diabetes

Increased Technology Use Associated With Lower A1C in a Large Pediatric Clinical Population

Refining the Definition of Stage 1 Type 1 Diabetes: An Ontology-Driven Analysis of the Heterogeneity of Multiple Islet Autoimmunity

Historical Insights and Current Perspectives on the Diagnosis and Management of Presymptomatic Type 1 Diabetes

Integration of Infant Metabolite, Genetic, and Islet Autoimmunity Signatures to Predict Type 1 Diabetes by Age 6 Years

Islet Autoantibody Levels Differentiate Progression Trajectories in Individuals With Presymptomatic Type 1 Diabetes

Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories.

High-throughput multiplex electrochemiluminescence assay applicable to general population screening for type 1 diabetes and celiac disease.

CGM Metrics Predict Imminent Progression to Type 1 Diabetes: Autoimmunity Screening for Kids (ASK) Study

Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes: Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S.

Tutorial: best practices and considerations for mass-spectrometry-based protein biomarker discovery and validation.

Collaborators (7)

Riitta Veijola

Greg Forlenza

Stephen Rich

Bart Keymeulen

Josefine Jönsson

Marian J Rewers

Bin Liu

Make your next move.